Science & Enterprise subscription

Follow us on Twitter

  • New contributed post on Science and Enterprise: https://t.co/XjQZgoAp3S Hands Off! Robots in Modern Medicine
    about 39 mins ago
  • Science funding is a mess. Could grant lotteries make it better? https://t.co/9akEDdSoVb via @voxdotcom
    about 14 hours ago
  • Researchers using a hand-held genomic sequencing device were able to identify targets for combating drug-resistant… https://t.co/5nE7VBwbBE
    about 19 hours ago
  • New post on Science and Enterprise: Portable Sequencer Identifies Drug-Resistant Bacteria https://t.co/6El4ePzZkx #Science #Business
    about 19 hours ago
  • Thank you @innerarchitect for all you do for lung health. Enjoy your weekend. https://t.co/nQRcgaZ2jH
    about 23 hours ago

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

RNA Therapy Studied for Parkinson’s Side Effects

Kathy Steece-Collier

Medical researchers are developing a treatment for a frequent side-effect of Parkinson’s disease drugs using a corrective RNA molecule to reverse the condition. . . . → Read More: RNA Therapy Studied for Parkinson’s Side Effects

Start-Ups Saying No Thanks to Venture Capital

Calculator cash calendar

Yesterday, we reported on 2018 being a banner year for venture capital, but the New York Times says a movement of entrepreneurs is looking for other ways to raise money. . . . → Read More: Start-Ups Saying No Thanks to Venture Capital

Infographic – Venture Finance Reaching Dot-Com Levels

Venture capital by year

Venture funding last year totaled $99.5 billion, the largest annual outlay since 2000. . . . → Read More: Infographic – Venture Finance Reaching Dot-Com Levels

Spin-Off Gains Seed Funds for Non-Opioid Pain Drug

Molly Shoichet

A company spun-off from a university medical materials lab received start-up funds to develop a non-opioid surgical pain therapy, including a clinical trial. . . . → Read More: Spin-Off Gains Seed Funds for Non-Opioid Pain Drug

Start-up Funds Univ. Medical Cannabis Research

Cannabis plant

A developer of therapies derived from cannabis is sponsoring a 3-year basic and translational research program, including clinical trials, at Imperial College London. . . . → Read More: Start-up Funds Univ. Medical Cannabis Research

Lilly Buys Precision Cancer Company in $8B Deal

Drug maker Eli Lilly and Company is acquiring a developer of cancer therapies that target specific genetic alterations rather than tumors in the body. . . . → Read More: Lilly Buys Precision Cancer Company in $8B Deal

Infographic – Nasdaq Biotech Index Recovers

Nasdaq Biotechnology Index

We’ll check in from time to time on the Nasdaq Biotechnology Index that tracks 223 biotech industry stocks. . . . → Read More: Infographic – Nasdaq Biotech Index Recovers

Govt. Shutdown Disrupts U.S. Science

U.S. Capitol

Several agencies that run or finance labs are closed, due to the lapse of funding for about a quarter of federal departments that began on 22 December. . . . → Read More: Govt. Shutdown Disrupts U.S. Science

Infographic – Tech IPOs Flat in 2018

Tech IPO pipeline

CB Insights recently issued its annual Tech IPO Report, showing the number of initial public stock offerings in the technology industries unchanged from 2017. . . . → Read More: Infographic – Tech IPOs Flat in 2018

Drug Discovery Start-Up Gains $400M Financing

Glasses, computer screens

A 2 year-old company using computational techniques to find protein-targeting drugs raised $400 million in new financing, led by the venture funding arm of Softbank. . . . → Read More: Drug Discovery Start-Up Gains $400M Financing